Emami to host Q1FY27 earnings call on Aug 4
Emami Limited announced it will host a conference call on August 4, 2026, at 4:00 PM IST to discuss its Q1FY27 unaudited financial results and business strategy. The call, disclosed under Regulation 30 of SEBI regulations, will feature key management personnel including Mr. Mohan Goenka and Mr. Vivek Dhir. Domestic and international dial-in access numbers have been provided for investors.

*this image is generated using AI for illustrative purposes only.
Emami Limited will host a conference call with analysts and investors on Tuesday, 4th August 2026, to discuss its business strategy and outlook following the declaration of its Q1FY27 unaudited financial results. The call is scheduled to begin at 4:00 PM IST and will provide insights into the company's performance for the quarter.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company secretary and compliance officer, Ravi Varma, confirmed the schedule in a filing sent to the National Stock Exchange of India Ltd. and BSE Limited.
Key management personnel will participate in the discussion to address queries from the investment community. The participants include Mr. Mohan Goenka, Wholetime Director & Vice Chairman, and Mr. Vivek Dhir, CEO (International Business). Other executives such as the Chief Growth Officer, President (Healthcare), President (Sales), and President (Finance & IR) will also be present.
The conference call details, including dial-in numbers for domestic and international participants, have been provided. Investors can access the call via universal access numbers in India or toll-free numbers from the USA, UK, Singapore, and Hong Kong. Specific time zones for international participants are Hong Kong/Singapore at 6:30pm, UK at 11:30am, and New York at 6:30am.
Conference Call Details
| Category | Details |
|---|---|
| Date / Time | Tuesday, 4th Aug 2026, 4:00PM IST |
| Management Participants | Mr. Mohan Goenka – Wholetime Director & Vice Chairman Mr. Vivek Dhir – CEO (International Business) Mr. Dhruv Aggarwal – Chief Growth Officer Mr. Gul Raj Bhatia – President (Healthcare) Mr. Manish Gupta – President (Sales) Mr. Rajesh Sharma – President (Finance & IR) |
| India Access | +91 22 6280 1259 / +91 22 7115 8160 |
| USA Toll-free | 18667462133 |
| UK Toll-free | 08081011573 |
| Singapore Toll-free | 8001012045 |
| Hong Kong Toll-free | 800964448 |
For further information, investors may contact Percy Panthaki or Siddhesh Deshmukh via the provided contact details.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.01% | +1.09% | +3.68% | -18.62% | -29.32% | -27.63% |
What specific growth drivers does Emami anticipate for its international business in FY27?
How will the company navigate potential inflationary pressures on raw material costs in the coming quarters?
What strategic initiatives are being prioritized to expand market share in the healthcare segment?































